This is the best thing about our higher education system. High tech labs with real scientists.
FOX 8 News reports:
Duke University testing drug that shows promise in fighting coronavirus, doctors sayMore than half of a group of severely ill coronavirus patients improved after receiving an experimental antiviral drug, although there’s no way to know the odds of that happening without the drug because there was no comparison group, doctors reported Friday.The results published by the New England Journal of Medicine are the first in COVID-19 patients for remdesivir. The Gilead Sciences drug has shown promise against other coronaviruses in the past and in lab tests against the one causing the current pandemic, which now has claimed more than 100,000 lives.No drugs are approved now for treating the disease. At least five large studies are testing remdesivir, and the company also has given it to more than 1,700 patients on a case-by-case emergency basis.Friday’s results are on 53 of those patients, ages 23 to 82, hospitalized in the United States, Europe, Canada and Japan. Thirty-four of them were sick enough to require breathing machines.All were given the drug through an IV for 10 days or as long as they tolerated it.After 18 days on average, 36 patients, or 68%, needed less oxygen or breathing machine support. Eight others worsened.
CLICK HERE FOR FULL VERSION OF THIS STORY